Website profile

Kalkine Media

Kalkine Media provides Stock Market News, NYSE News, Financial News, United State Stocks Research Analysis, Latest coverage on all NYSE Listed Companies for all sectors.

  • 2,922articles · 30d
  • 9+ hour agolatest article
  • Aug 15, 2026earliest in window
  • 92%with images
  • 145avg words
articles per day
Categories
  • Economy, Business & Finance 2,849
  • Finance & Business 2,593
  • News 1,841
  • Business & Industrial 596
  • Finance 394
  • Industrial 275
  • Science & Technology 28
  • Health & Wellness 25

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

@kalkineau
kalkinemedia.com > au > news > announcements > arovella-therapeutics-unveils-first-clinical-batch-of-ala-101-and-launches-initial-trial-site-at-the-alfred

Arovella Therapeutics Unveils First Clinical Batch of ALA-101 and Launches Initial Trial Site at The Alfred

1+ week, 14+ hour ago   (94+ words) Kalkine Media Why Is WiseTech Global (ASX:WTC) in Focus? What Changed for BHP (ASX:BHP) Dividends After Results? Why Is CSL (ASX:CSL) Back on Dividend Watch? Arovella Therapeutics (ASX:ALA) ALA (ASX:ALA) has successfully manufactured and released…...

@kalkineca
kalkinemedia.com > ca > news > featured-news > kane-biotech-tsx-v-kne-unlocks-ontario-health-athome-formulary-access-through-oms-partnership-1

Kane Biotech (TSX-V: KNE) Unlocks Ontario Health atHome Formulary Access Through OMS Partnership

1+ week, 15+ hour ago   (315+ words) Millions of patients. Tens of millions of nursing visits. And at the center of it all, a stubborn clinical challenge that drains resources and resists conventional treatment. Kane Biotech (TSX-V:KNE) is moving decisively into this space, and its latest…...

@kalkineau
kalkinemedia.com > au > news > announcements > ltr-pharma-secures-exclusive-pilot-deal-to-launch-kyzatrex-oral-testosterone-therapy-in-australia

LTR Pharma Secures Exclusive Pilot Deal to Launch KYZATREX® Oral Testosterone Therapy in Australia

1+ week, 6+ day ago   (91+ words) Is RHC (ASX:RHC) Making Waves Across the ASX 200? Why AUC (ASX:AUC) Is Back in Focus as Oil Shakes the ASX? Why Could BHP (ASX:BHP) Face a Tough September? Why X2M (ASX:X2M) Is Expanding Into Australia’s AI Data Centre…...

@kalkineus
kalkinemedia.com > us > news > announcements > tandem-diabetes-care-ceo-john-f-sheridan-reports-august-2026-rsu-vesting-and-tax-withholding-details

Tandem Diabetes Care CEO John F. Sheridan Reports August 2026 RSU Vesting and Tax Withholding Details

3+ week, 5+ day ago   (236+ words) John F. Sheridan, President and CEO of Tandem Diabetes Care Inc. (NASDAQ:TNDM) TNDM (NASDAQ:TNDM), submitted a Form 4 on August 18, 2026, revealing restricted stock unit vesting activity dated August 15, 2026. The August 15, 2026 transactions involved the vesting of RSUs from two distinct grants....